Miss Cecily Chen, UCB China, Medical Manager CNS was also in attendance.
The purpose of this meeting was to discuss further Asia Pacific collaboration with UCB and the China Association Against Epilepsy.
Lee Gervitz, UCB Asia Pacific, newly appointed Senior Medical Director, Head of Medical Affairs, Asia-Pacific detailed UCB’s program and its new patient-driven focus.
The company’s new slogan is ‘UCB, Inspired by patients and Driven by science’.
Ms Echo Gu is the NBT Director and responsible for the Keppra brand.
UCB strongly supports the China Association Against Epilepsy and has assisted with funding to establish and maintain four Patient Activity Centers in Beijing, Shanghai, Xi’an and Dalian in China.
Pictured (left – right) : Professor Ding Ding, Institute of Neurology, Fudan University, Shanghai; IBE Vice President, Western Pacific Region with IBE Treasurer, Robert Cole; Echo Gum UCB China, NBT Director, Keppra; and Lee Gervitz, UCB China, Senior Medical Director, Head of Medical Affairs, Asia-Pacific.